Sign in

Alastair Borthwick

Executive Vice President and Chief Financial Officer at BAC
Executive

About Alastair Borthwick

Alastair M. Borthwick is Chief Financial Officer of Bank of America (appointed November 2021), responsible for accounting, balance sheet management, FP&A, corporate treasury, investor relations, corporate investments, and tax . For performance year 2024, total compensation was $15.5M (Salary $1.0M; Annual Cash Incentive $4.35M; PRSUs $5.075M; TRSUs $5.075M), up 29% vs. 2023, reflecting disciplined balance sheet, capital and liquidity management amid an uncertain rate environment . Company-level context during his tenure includes 2024 revenue of $101.9B (+3% YoY), diluted EPS $3.21, and book value per share growth of 7% with strong liquidity ($953B average GLS in 4Q24) . He was 53 in the September 2021 8‑K announcing his appointment as CFO .

Past Roles

OrganizationRoleYearsStrategic Impact
Bank of AmericaPresident, Global Commercial Banking2012–Q4 2021Led GCB prior to becoming CFO .

External Roles

  • Not disclosed in the 2025 and 2024 proxy statements reviewed for Mr. Borthwick .

Fixed Compensation

Multi-year total compensation decisions (performance year basis):

Metric2021202220232024
Total Compensation ($)11,000,000 10,500,000 12,000,000 15,500,000

2023 and 2024 compensation mix (performance year basis):

Component2023 ($)2024 ($)
Base Salary1,000,000 1,000,000
Annual Cash Incentive3,300,000 4,350,000
Performance RSUs (PRSUs)3,850,000 5,075,000
Time-based RSUs (TRSUs)3,850,000 5,075,000
Total12,000,000 15,500,000

Notes:

  • For NEOs other than the CEO, the Committee increased the long‑term equity mix to 70% and decreased cash to 30% to further align with shareholders .

Performance Compensation

Performance plan design and realized outcomes:

PRSU CycleMetricWeightTarget StandardActualPayoutVesting
2021–20233‑yr avg ROA50%≥80 bps92 bps100%3‑yr performance; stock‑settled; max 100%
2021–20233‑yr avg adj. TBV growth50%≥8.5%11.09%100%3‑yr performance; stock‑settled; max 100%
2022–20243‑yr avg ROA (tax‑normalized)50%≥80 bps85 bps100%3‑yr performance; stock‑settled; max 100%
2022–20243‑yr avg adj. TBV growth50%≥8.5%11.41%100%3‑yr performance; stock‑settled; max 100%

Equity grants (award structure and sizing):

Grant YearAward TypeGrant DateUnits (Target/Granted)Grant Date Fair Value ($)
2024PRSU2/15/2024115,825 target 3,452,894
2024TRSU2/15/2024115,825 granted 3,699,524
2023PRSU2/15/202379,101 target 2,469,945
2023TRSU2/15/202379,101 granted 2,469,945

Key vesting schedules and performance periods:

  • 2023 TRSUs: 25% per year on Feb 15 of 2024, 2025, 2026, 2027 .
  • 2022 TRSUs: Vest one‑third on Feb 15, 2024; one‑third on Feb 15, 2025; one‑third on Feb 15, 2026 .
  • 2023 PRSUs: 3‑year performance period ending Dec 31, 2025; target is the max; stock‑settled if earned .
  • 2024 PRSUs: 3‑year performance period (granted Feb 2024; target is the max); stock‑settled if earned .

Clawbacks and risk controls:

  • Equity awards are subject to multiple cancellation and clawback features, including the Incentive Compensation Recoupment Policy, detrimental conduct provisions, and anti‑hedging/derivatives policy compliance .

Equity Ownership & Alignment

Ownership and unvested equity:

As of DateCommon Stock Beneficially Owned (#)Unvested RSUs – TRSUs (#)Unvested RSUs – PRSUs (#)Total Stock Units (#)
Mar 1, 2024326,855 371,693 259,376 (assumes 100% of PRSUs) 631,069
  • Each individual executive and all executives as a group beneficially own less than 1% of outstanding common stock; no stock options outstanding (company has not granted options/SARs since 2008) .

Year-end outstanding equity (selected line items; 12/31/2024):

  • Unvested TRSUs: 39,317 (2021 TRSUs; vested 2/15/2025); 32,225 (2022 TRSUs; half vested 2/15/2025; remaining vests 2/15/2026); 59,326 (2023 TRSUs); 115,825 (2024 TRSUs) .
  • Unearned PRSUs: 79,101 (2023 PRSUs; performance through 2025); 115,825 (2024 PRSUs) .
  • Some cash‑settled units (e.g., 25,000 and 50,000 RSUs) are noted in outstanding awards; see footnotes in the table for treatment .

2023 stock vested:

MetricShares Acquired on Vesting (#)Value Realized ($)
2023241,3528,385,227
Of which cash‑settled units50,000Included above

Ownership/retention and pledging/hedging:

  • Ownership requirement: 300,000 shares for executive officers; must retain 50% of net after‑tax shares from equity awards until retirement; all NEOs in compliance .
  • Hedging and speculative trading prohibited for directors and executive officers .
  • Pledging of equity-based awards prohibited under plan/policies .

Nonqualified deferred compensation and pension:

Plan/Benefit2024 Executive Contributions ($)2024 Aggregate Earnings ($)Aggregate Balance 12/31/2024 ($)
Deferred Compensation Plan073,415293,549
Pension PlanYears Credited Service (#)Present Value of Accumulated Benefit ($)
Legacy Pension Plan6.8371,011
Legacy Pension Restoration Plan6.831,675

Employment Terms

Appointment and pay programs:

  • Appointed CFO Q4 2021 with $1,000,000 base salary and participation in annual incentive and equity programs under BACEP .

Change-in-control and termination treatment (equity):

  • Double-trigger: If terminated without cause or for “good reason” within two years after a change in control, PRSUs are earned at 100% and paid per original schedule; TRSUs continue per schedule (subject to performance‑based cancellation and covenants) .
  • “Good reason” includes material diminution in responsibility, material base salary reduction (with exceptions), or relocation >50 miles; notice and cure required .
  • No executive CIC agreements; severance agreements for executive officers are not used; policy requires shareholder approval for severance benefits exceeding 2× base salary+bonus for executive officers .

Potential payments from RSUs (as of 12/31/2024):

ScenarioPayable Immediately ($)Payable per Award Schedule ($)
Death26,696,426
Disability026,696,426
Termination w/ good reason or without cause within 2 years post‑CIC26,696,426
All other terminations except for cause23,168,521

Award covenants:

  • Continued vesting/eligibility is conditioned on non‑solicitation, avoidance of detrimental conduct, and compliance with anti‑hedging/derivatives policies; some awards allow continued vesting for workforce reduction/divestiture .

Clawbacks and governance:

  • Multiple cancellation and clawback features apply; independent control functions review and certify incentive plans; anti‑hedging policy enforced .

Perquisites and other comp (illustrative):

  • 2024: Benefits/tax/financial advisory services $26,435; 401(k)/qualified plan match $20,000; aircraft use $0; tax equalization $0 .
  • 2023: Benefits/tax/financial advisory services $31,560; 401(k)/qualified plan match $20,000; aircraft use $0; tax equalization $0 .

Investment Implications

  • Strong pay-for-performance alignment: 70% of non‑CEO NEO variable pay delivered in long‑term equity; PRSUs tied to rigorous three-year ROA and adjusted TBV standards with no upside beyond target and documented 100% payouts for 2021–2023 and 2022–2024 cycles; robust clawbacks and retention requirements enhance alignment and reduce risk of short‑termism .
  • Selling pressure assessment: Known vesting cadence (2021 TRSUs vested on 2/15/2025; 2022 TRSUs further vest on 2/15/2026; 2023 TRSUs vest annually through 2027; PRSUs complete in 2025 and 2026) could create periodic supply, partially mitigated by the requirement to retain 50% of net after‑tax shares until retirement and the absence of options .
  • Retention risk appears contained: Significant unvested equity and potential deferred payouts under standard and CIC scenarios (e.g., $26.7M payable per schedule in certain cases) support retention; pension/deferred comp balances are modest relative to equity, reinforcing equity‑based retention .
  • Governance risk flags low: Prohibitions on hedging and pledging, no CIC agreements or tax gross‑ups, double‑trigger equity treatment, and policy caps on severance underscore shareholder‑friendly practices; Say‑on‑Pay support of 91.4% in 2024 corroborates investor acceptance of design .

Overall, Borthwick’s package emphasizes long‑term equity with rigorous PRSU metrics and meaningful retention/recoupment features; upcoming vest schedules and PRSU performance conclusions represent the primary timing catalysts for potential insider selling activity.

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%